Tatva Chintan Pharma Chem Ltd. IPO

It is India’s first and world’s second-largest commercial manufacturer of SDAs for zeolites (used in batteries).

Open Demat Account

Tatva Chintan Pharma Chem Ltd. IPO Details

Check out the issue details for Tatva Chintan Pharma Chem Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 1083

Price Band

₹ 1073 - 1083

Issue Size

500.00 Cr.

Issue Type

Book Built

Open

2021-07-16

Close

2021-07-20

Listing price

₹ 2111.85

Listing Gain

95.00%

Listing Date

2021-07-29

CMP

₹ 1681.4

Current Return

55.25%

Company Financials

You can get the following financial statements of Tatva Chintan Pharma Chem Ltd. as of now.

The valuation of Tatva Chintan Pharma IPO company based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 1083
Total Shares 2.22 Cr
Market Cap 2404 Cr
EPS  Rs 23.17 
PE Ratio 47x
Industry PE 56x

 

Tatva Chintan Pharma IPO issue size is 500 Cr. 

Issue Amount
Fresh Issue 225 Cr
Offer For Sale 275 Cr

 

An Individual can apply for a minimum 1 lot of 13 shares and a maximum of 14 lots of 182 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 13 Rs 14,079
 Maximum 14 182 Rs 1,97,106

 

Tatva Chintan Pharma IPO is subscribed 180.36 times till 20th July. It is Oversubscribed as of now. The category-wise subscription is as follows:

Category % Offered Subscription 
Qualified Institutional Maximum 50% 185.23 Times
Non-Institutional Minimum 15% 512.22 Times
Retail Individual Minimum 35% 35.53 Times
Total 100% 180.36 Times

Once you have subscribed to an IPO, you have to wait for its allotment to your account. Find below the dates of allotment of Tatva Chintan Pharma IPO:

Schedule Date
Basis of Allotment 26 August 2021
Refunds 27 August 2021
Credit to Demat Account 28 August 2021
IPO Listing Date 29 August 2021

When the allotment is out, you can check it from the registrar's website. Find the Tatva Chintan Pharma IPO allotment status here.

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 427.81 403.04 378.68 366.42 496.3
Total Expenditure 321.81 348.23 311.66 340.41 406.81
Operating Profit 106.01 54.82 67.01 26.01 89.49
Other Income 10.63 5.68 7.51 3.56 3.53
Interest 5.19 8.52 6.66 1.45 3.01
Depreciation 8.18 9.55 25.6 27.65 36.84
Exceptional Items 0 -3.59 0 0 0
Profit Before Tax 103.27 38.83 42.27 0.46 53.17
Provision for Tax 7.28 -1.63 12.92 0.13 14.08
Net Profit 95.99 40.47 29.35 0.33 39.08
Adjusted EPS (Rs.) 4.33 1.83 1.25 0.01 1.67

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 22.17 22.17 23.39 23.39 23.39
Total Reserves 446.71 482.62 702.49 697.92 734.84
Borrowings 13.11 4.23 0.64 0 5.01
Other N/C liabilities -8.05 -15.26 -10.96 -10.86 -4.38
Current liabilities 193.55 246.58 87.21 100.09 228.35
Total Liabilities 667.49 740.34 802.77 810.55 987.21
Assets
Net Block 159.61 196.22 426.87 528.66 609.39
Capital WIP 51.49 230.74 72.93 21.54 23.35
Intangible WIP 0 0 3.61 2.78 1.57
Investments 0.67 0.67 0.67 0.67 4.67
Loans & Advances 2.09 2.66 4.26 4.28 4.58
Other N/C Assets 0.51 0.55 0.83 1.11 1.72
Current Assets 453.12 309.49 293.61 251.52 341.95
Total Assets 667.49 740.34 802.77 810.55 987.21
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Other Income 1.37 0.79 1.73 -0.37 4.03
Profit Before Tax 7.05 12.34 18.79 14.98 14.09
Tax 1.92 3.4 2.81 5.95 3.65
Profit After Tax 5.13 8.94 15.98 9.02 10.45
Adjusted EPS (Rs) 2.19 3.82 6.83 3.86 4.47

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 72.02 0
Mar 2026 72.02 0
Dec 2025 72.02 0
Sep 2025 72.02 0
Jun 2025 72.02 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 103.27 38.83 42.27 0.46 53.17
Adjustment 9.64 15.82 28.17 28.34 41.29
Changes in Assets & Liabilities -75.18 -23.18 38.81 -0.35 -61.06
Tax Paid -17.97 -7.74 -6.48 -4.44 -4.24
Operating Cash Flow 19.76 23.73 102.78 24.01 29.17
Investing Cash Flow -196.72 -101.13 -120.52 -65.38 -115.83
Financing Cash Flow 235.01 37.82 30.54 16.59 78.93
Net Cash Flow 58.05 -39.59 12.8 -24.78 -7.73
X